Breaking News

Panthera Relocates to Health Innovation Hub

The move allows Panthera to expand its operations, increase capacity and offer further opportunities for people in Glasgow to take part in clinical research.

Author Image

By: Charlie Sternberg

Associate Editor

Panthera, an independent Site Management Organization (SMO) specializing in patient recruitment and clinical trial management for global pharmaceutical companies, has relocated its Glasgow Clinical Research site from the Clinical Innovation Zone (CIZ) at Queen Elizabeth University Hospital to the Health Innovation Hub (HiH) in the Glasgow Riverside Innovation District (GRID). The facility, which is open to patients, features eight bespoke clinical rooms, laboratory facilities, and modern office space.

The move to the HiH will allow Panthera, which currently has six sites across the UK and is expanding into Europe, to expand its operations, increase capacity and offer further opportunities for people in Glasgow to take part in clinical research.

Stuart Young, CEO of Panthera, said, “We are delighted to be moving into this new center of excellence as we expand to meet the growing demand from our sponsors and patients. More people in Glasgow will now have the chance to participate in clinical trials, gaining early access to cutting-edge treatments for life-changing conditions well before they become widely available through the NHS.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics